1
052
Chem. Pharm. Bull.
Vol. 63, No. 12 (2015)
(
6L) and 1-BuOH (6L), successively, to give 100g and 126g
Crotocascarin J (2)
Amorphous powder, [α] +9.1 (c=0.64, CHCl ); IR ν
max
2
4
of EtOAc and 1-BuOH-soluble fractions, respectively. The
remaining water-layer was concentrated to give a H O- (KBr) cm : 3433, 2929, 2874, 1745, 1645, 1415, 1384, 907;
soluble-fraction (263g). The 1-BuOH-soluble fraction was UV λmax (MeOH) nm (logε): 220 (3.54); H-NMR (400MHz,
D
3
−1
2
1
subjected to a Diaion HP-20 column (Φ=80mm, L=57cm), CDCl ) δ: 5.06 (1H, s, H-18a), 5.04 (1H, s, H-18b), 4.18 (1H,
3
and eluted with H O–MeOH (4:1, 6L), (3:2, 6L), (2:3, 6L), d, J=5.1Hz, H-1), 3.35 (1H, d, J=12.6Hz, H-13), 3.11 (1H, s,
2
and (1:4, 6L), and MeOH (6L), 1L-fractions being collected. H-5), 2.97 (1H, dd, J=12.6, 1.1Hz, H-7), 2.53 (1H, m, H-10a),
The residue (6.38g) in fractions 10–14 was subjected to silica 2.41 (1H, m, H-11a), 2.39 (1H, dd, J=13.5, 7.0Hz, H-3a), 2.33
gel CC (Φ=36mm, L=57cm), and eluted with CHCl (1.5L), (1H, ddd, J=14.8, 13.4, 6.4Hz, H-11b), 2.04 (1H, m, H-2),
3
CHCl –MeOH (99:1, 1.5L), (97:3, 1.5L), (19:1, 1.5L), (37:3, 1.89 (3H, d, J=0.9Hz, H -17), 1.68 (1H, dd, J=13.5, 10.2Hz,
3
3
1
.5L), (9:1, 1.5L), (7:1, 1.5L), (17:3, 1.5L), (33:7, 1.5L), H-3b), 1.56 (1H, ddd, J=13.6, 13.2, 5.7Hz, H-10b), 1.14 (3H,
13
(
2
4:1, 1.5L), (3:1, 1.5L), and (7:3, 1.5L), and MeOH (1.5L), s, H -20), 1.03 (3H, d, J=7.2Hz, H -19); C-NMR (100MHz,
50mL-fractions being collected. The residue (1.61g) in frac- CDCl ): Table 1; CD Δε (nm): +2.54 (255), −2.71 (223)
3
5
3
3
−
tions 59–79 was separated by ODS open CC to give 50.6mg (c=1.78×10 M, MeOH); HR-ESI-MS (positive-ion mode) m/z:
+
of crude 6 in fractions 58–64, which was finally purified by 383.1464 [M+Na] (Cacld for C H O Na: 383.1465).
HPLC (H O–MeOH, 3:2) to afford 2.9mg of pure 6 from the
peak at 5.4min.
2
0
24
6
Crotocascarin K (3)
Colorless plates, mp 244–245°C; [α]
2
2
4
+96.7 (c=0.15,
(KBr) cm : 3435, 2924, 2857, 1739, 1634,
max
D
−1
The residue (6.90g) in fractions 15–18 obtained on Diaion CHCl ); IR ν
3
HP-20 CC was subjected to silica gel CC (Φ=36mm, L=57 cm), 1406, 1384, 904; UV λ
(MeOH) nm (logε): 218 (3.99);
H-NMR (400MHz, CDCl ) δ: 5.24 (2H, s, H-18a, 20a), 5.09
max
1
and eluted with CHCl3 (1.5L), CHCl –MeOH (99:1, 1.5L),
3
3
(97:3, 1.5L), (19:1, 1.5L), (37:3, 1.5L), (9:1, 1.5L), (7:1, (2H, s, H-18b, 20b), 5.06 (1H, m, H-9), 4.42 (1H, s, H-5), 4.15
1.5L), (17:3, 1.5L), (33:7, 1.5L), (4:1, 1.5L), (3:1, 1.5L), (1H, d, J=5.2Hz, H-1), 3.55 (1H, dd, J=11.7, 0.7Hz, H-7),
and (7:3, 1.5L), and MeOH (1.5L), 250mL-fractions being 2.88 (1H, d, J=11.7Hz, H-13), 2.60 (2H, m, H-10a, 11a), 2.41
collected. The residue (921mg) in fractions 42–52 was sepa- (1H, dd, J=13.7, 7.2Hz, H-3a), 2.27 (1H, m, H-11b), 2.03 (1H,
rated by ODS open CC and the residue (45.7mg) in fractions m, H-2), 1.69 (3H, d, J=1.1Hz, H -17), 1.53 (1H, dd, J=13.7,
3
1
5
88–193 was then purified by DCCC to give 9.6mg of crude 10.2Hz, H-3b), 1.27 (1H, m, H-10b), 1.00 (3H, d, J=7.1Hz,
13
in fractions 87–97, which was finally purified by HPLC H -19); C-NMR (100MHz, CDCl ): Table 1; CD Δε (nm):
3
3
−5
(
H O–MeOH, 3:2) to afford 5.4mg of pure 5 from the peak +16.6 (226) (c=4.45×10 M, MeOH); HR-ESI-MS (positive-
2
at 20.0min.
ion mode) m/z: 367.1516 (Calcd for C H O Na: 367.1515).
20 24 5
The residue (11.7g) in 19–24 fractions obtained on Diaion
HP-20 CC was subjected to silica gel CC (Φ=50mm, L=57cm),
Crotocascarin γ (4)
Amorphous powder, [α] +21.8 (c=0.07, CHCl ); IR ν
max
2
3
D
3
−1
and eluted with CHCl (3L), CHCl –MeOH (99:1, 3L), (97:3, (film) cm : 3420, 2957, 2930, 1757, 1711, 1454, 1150, 891;
3
3
1
3
L), (19:1, 3L), (37:3, 3L), (9:1, 3L), (7:1, 3L), (17:3, 3L),
H-NMR (400MHz, CD OD) δ: 5.19 (1H, brs, H-18a), 4.91
3
(
33:7, 3L), (4:1, 3L), (3:1, 3L), and (7:3, 3L), and MeOH (1H, s, H-18b), 4.39 (1H, d, J=5.0Hz, H-1), 4.28 (1H, s, H-5),
(3L), 500mL-fractions being collected. The residue (598mg) 3.15 (1H, brd, J=13.6Hz, H-13), 2.85 (1H, d, J=13.6Hz, H-7),
in fractions 19–24 was subjected to ODS open CC and the 2.50 (1H, m, H-11a), 2.36 (3H, s, H -17), 2.20 (3H, overlapped,
3
residue (32.5mg) in fractions 118–124 was purified by HPLC H-10a, b, 11b), 2.19 (1H, dd, J=13.8, 7.3Hz, H-3a), 1.95 (1H,
(
2
H O–MeOH, 3:2) to afford the residue from the peak at m, H-2), 1.51 (1H, dd, J=13.8, 10.6Hz, H-3b), 1.20 (3H, s,
2
13
2min, which was then purified again by HPLC (Inertsil Ph-3, H -20), 1.00 (3H, d, J=7.2Hz, H -19); C-NMR (100MHz,
3
3
H O–MeOH, 13:7) to give 1.3mg of 4 and 3.4mg of 3 from CD OD): Table 1; HR-ESI-MS (positive-ion mode) m/z:
2
3
the peaks at 22min and 24min, respectively. Crotocascarins J 371.1475 (Calcd for C H O Na: 371.1465).
19
24
6
(
1
2) (59.8mg) and I (1) (6.3mg) were obtained from fractions
47–155 and 155–162, respectively.
Crotocascarin I (1)
Amorphous powder, [α] +32.0 (c=0.65, CHCl ); IR ν
Isocrotofolane Glucoside (5)
2
4
Amorphous powder, [α] −63.6 (c=0.36, MeOH); IR νmax
D
1
−
(film) cm : 3378, 2930, 2876, 1690, 1646, 1457, 1380, 1077,
897; UV λ (MeOH) nm (logε): 234 (3.84), 211 (3.79);
2
6
D
3
max
max
−1
1
(
KBr) cm : 3478, 2939, 2873, 1739, 1644, 1452, 1014, 904;
H-NMR (400MHz, CD OD) δ: 6.29 (1H, d, J=6.0Hz, H-8),
3
1
UV λmax (MeOH) nm (logε): 223 (3.75); H-NMR (400MHz, 4.62 (1H, s, H-18a), 4.60 (1H, d, J=1.1Hz, H-5), 4.49 (1H,
CDCl ) δ: 5.07 (1H, s, H-18a), 5.06 (1H, s, H-18b), 4.92 (1H, d, J=7.3Hz, H-1′), 4.28 (1H, s, H-18b), 3.93 (1H, dd, J=11.9.
3
ddq, J=12.0, 3.6, 1.2Hz, H-9), 4.20 (1H, d, J=5.4Hz, H-1), 1.8Hz, H-6′a), 3.69 (1H, dd, J=11.9, 5.9Hz, H-6′b), 3.33
3.11 (1H, s, H-5), 3.08 (1H, d, J=12.6Hz, H-7), 2.90 (1H, d, (4H, m, H-2′, 3′, 4′, 5′), 3.16 (1H, m, H-3a), 2.65 (1H, brd,
J=12.6Hz, H-13), 2.58 (1H, dddd, J=12.6, 4.2, 3.6, 3.6Hz, J=8.8Hz, H-13), 2.56 (1H, m, H-11a), 2.51 (1H, m, H-10a),
H -10a), 2.55 (1H, ddd, J=13.2, 3.6, 3.6Hz, H-11a), 2.41 (1H, 2.45 (1H, m, H-2), 2.35 (1H, m, H-3b), 2.27 (1H, dd, J=8.8,
2
dd, J=13.8, 7.2Hz, H-3a), 2.19 (1H, ddd, J=13.2, 12.6, 4.2Hz, 6.0Hz, H-7), 2.00 (2H, m, H-10b, 11b), 1.39 (3H, s, H -20),
3
H-11b), 2.02 (1H, ddqd, J=10.6, 7.2, 7.2, 5.4Hz, H-2), 1.91 1.35 (3H, s, H -17), 1.34 (3H, s, H -16), 1.11 (3H, d, J=7.3Hz,
3
3
1
3
(
1
3H, d, J=1.2Hz, H -17), 1.65 (1H, dd, J=13.8, 10.6Hz, H-3b), H -19); C-NMR (100MHz, CD OD): Table 1; HR-ESI-
3
3
3
+
.21 (1H, dddd, J=13.2, 12.6, 12.0, 4.2Hz, H -10b), 1.05 (3H, MS (positive-ion mode) m/z: 517.2385 [M+Na] (Calcd for
2
13
s, H -20), 1.02 (3H, d, J=7.2Hz, H -19); C-NMR (100MHz, C H O Na: 517.2408).
3
3
26 38
9
−5
CDCl ): Table 1; CD Δε (nm): +1.42 (252) (c=1.91×10 M,
MeOH); HR-ESI-MS (positive-ion mode) m/z: 367.1514
[
Compound 6 (6)
Amorphous powder, [α] −93.6 (c 0.19, MeOH); IR νmax
(film) cm : 3364, 2928, 1503, 1255, 1069; UV λ
3
2
5
D
+
−1
M+Na] (Cacld for C H O Na: 367.1515).
(MeOH)
2
0
24
5
max
1
nm (logε): 333 (2.74), 269 (3.25), 220 (3.57); H-NMR